How Vox analyzed and explained the high prices in emergency departments

When Sarah Kliff, healthcare reporter for Vox, saw an emergency department bill charging more than $600 for an encounter that ended with a band-aid, she and the media company undertook a year-long project to explore as many ED bills as possible. She sought to answer why ED prices are so high and continue to rise so quickly.

She revealed her findings in a series of reporting over the year, after collecting hundreds of medical bills. More recently, Kliff wrote a viewpoint on the experience and results of the project in JAMA Internal Medicine.

For patients, one of the most common and biggest problems with ED bills was surprise bills, when they received charges from an out-of-network clinician after receiving care from an in-network hospital. Some of Kliff’s reporting even led one hospital to change its billing policy after patients were left with tens of thousands in medical bills and the outrage hit the news.

See the full viewpoint below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.